CIP
KURA icon

Chartwell Investment Partners’s Kura Oncology KURA Stock Holding History

Chartwell Investment Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,992
Closed -$476K – 432
2021
Q4 		$476K Sell
33,992
-848
-2% -$13.7K 0.01% 410
2021
Q3 		$653K Hold
34,840
– – 0.02% 402
2021
Q2 		$726K Buy
34,840
+322
+0.9% +$7.99K 0.02% 395
2021
Q1 		$976K Sell
34,518
-1,855
-5% -$58.7K 0.03% 362
2020
Q4 		$1.19M Sell
36,373
-8,300
-19% -$292K 0.04% 348
2020
Q3 		$1.37M Hold
44,673
– – 0.05% 320
2020
Q2 		$728K Buy
+44,673
New +$644K 0.03% 356

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Chartwell Investment Partners's KURA Position: Q1 2022 in Review

Chartwell Investment Partners sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 33,992 shares — an estimated $476K sold.

Chartwell Investment Partners first reported a position in KURA in Q2 2020 and held it in 7 quarters. The position peaked at $1.37M in Q3 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Chartwell Investment Partners reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 33,992 Kura Oncology shares in Q1 2022, an estimated $476K.
  • Chartwell Investment Partners first reported a position in Kura Oncology in Q2 2020 and held it in 7 quarters.
  • Chartwell Investment Partners's Kura Oncology position peaked at $1.37M in Q3 2020.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Chartwell Investment Partners's 13F filing for Q1 2022, filed 26 Apr 2022.